BIOGEN IDEC
BIOGEN IDEC operates in Diversified Metals & Mining.
BIOGEN IDEC (IDP) - Total Assets
Latest total assets as of September 2024: €28.31 Billion EUR
Based on the latest financial reports, BIOGEN IDEC (IDP) holds total assets worth €28.31 Billion EUR as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
BIOGEN IDEC - Total Assets Trend (2016–2023)
This chart illustrates how BIOGEN IDEC’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
BIOGEN IDEC - Asset Composition Analysis
Current Asset Composition (December 2023)
BIOGEN IDEC's total assets of €28.31 Billion consist of 25.6% current assets and 74.5% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 3.9% |
| Accounts Receivable | €2.10 Billion | 7.8% |
| Inventory | €2.53 Billion | 9.4% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €8.36 Billion | 31.2% |
| Goodwill | €6.22 Billion | 23.2% |
Asset Composition Trend (2016–2023)
This chart illustrates how BIOGEN IDEC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BIOGEN IDEC's current assets represent 25.6% of total assets in 2023, a decrease from 38.2% in 2016.
- Cash Position: Cash and equivalents constituted 3.9% of total assets in 2023, down from 10.2% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 54.0% of total assets, an increase from 32.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 31.2% of total assets.
BIOGEN IDEC Competitors by Total Assets
Key competitors of BIOGEN IDEC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MANHATTAN ASSOC
BE:MHT
|
Germany | €698.14 Million |
|
TV BROADCAST
MU:TBCN
|
Germany | €6.25 Billion |
|
FIRST CITIZENS BC A
BE:FC6A
|
Germany | €220.57 Billion |
|
COSTCO WHSL
MU:CTO
|
Germany | €69.83 Billion |
|
GOLDMAN SACHS GROUP - Dusseldorf Stock Exchang
DU:GOS
|
Germany | €1.73 Trillion |
|
BURCKHARDT COMPRE N
MU:B5H
|
Germany | €1.07 Billion |
|
Public Service Company of New Mexico PFD 4.58%
PINK:PNMXO
|
USA | $886.19 Million |
|
2H0
F:2H0
|
Germany | €15.27 Million |
BIOGEN IDEC - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - BIOGEN IDEC generates 0.37x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, BIOGEN IDEC generates $ 4.33 in net profit.
BIOGEN IDEC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.26 | 1.68 | 1.72 |
| Quick Ratio | 0.80 | 1.09 | 1.56 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €1.41 Billion | € 3.43 Billion | € 3.52 Billion |
BIOGEN IDEC - Advanced Valuation Insights
This section examines the relationship between BIOGEN IDEC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 9.3% |
| Total Assets | €26.84 Billion |
| Market Capitalization | $1.55 Million USD |
Valuation Analysis
Below Book Valuation: The market values BIOGEN IDEC's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: BIOGEN IDEC's assets grew by 9.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for BIOGEN IDEC (2016–2023)
The table below shows the annual total assets of BIOGEN IDEC from 2016 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | €26.84 Billion | +9.33% |
| 2022-12-31 | €24.55 Billion | +2.83% |
| 2021-12-31 | €23.88 Billion | -3.01% |
| 2020-12-31 | €24.62 Billion | -9.60% |
| 2019-12-31 | €27.23 Billion | +7.69% |
| 2018-12-31 | €25.29 Billion | +6.92% |
| 2017-12-31 | €23.65 Billion | +3.39% |
| 2016-12-31 | €22.88 Billion | -- |